This study provides new estimates of systematic risk and the cost of equity capital for the pharmaceutical, biotechnology, and medical device sectors using data for firms with publicly-traded stock on U.S. exchanges during 2001-2005 and 2006-2008. Two frameworks are employed for estimating...

The path from invention to innovation is a complex process where several factors play a critical role in the success of it. The biotechnology industry has almost three decades creating commercial products and emerging and growing as an entrepreneurial business with strong ties to science and...

Small, young life science ventures are simultaneously affected by strong global and local forces. These are reflected in the strategic orientations - like market orientation, entrepreneurial orientation, and technological orientation - adopted by the ventures. This chapter presents a comparison...

The present paper extends the literature investigating key drivers leading certain patents to exert a stronger influence on the subsequent technological developments (inventions) than other ones. We investigated six key determinants, as (i) the use of scientific knowledge, (ii) the breadth of...

Biotechnology and the WTO have increasingly intersected following the growth of biotech trade. The regulatory challenge of biotechnology is a current subject of debate in the WTO. Biotechnology highlights emerging tensions between the effectiveness of the WTO law on biotech issues and the public...

In Knowledge Based Bio-Economy over the past two decades, biotechnology has provided a motor for environmentally sustainable production and for the development of a diverse range of innovative products. The paper presents the possibility of using euclidean distance from the Positive Development...

This article deals with the business prospects of the biotechnology industry and portrays it as global sunrise industry. The biotech industry classification and the recent trends are outlined in the first part. The structure and the pattern of the industry in different countries have also been...

Ex situ collections that hold genetic materials operate as contractual points of articulation between countries of origin and recipients and/or prospective developers. In that capacity, collections are in a position both to negotiate clarification of Convention on Biological Diversity...

The concept of business models has in recent years become popular in connection with researching company level organizational change. Using the example of medical biotechnology this paper introduces, after a brief review of the business models literature, a perspective which theorizes business...